Daehwa Pharmaceutical Co., Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Hoengseong Korea, Republic of (1984)
Status: No NME R&D (1984)

Organization Overview

First Clinical Trial
2010
NCT02890511
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Daehwa Pharmaceutical Co., Ltd.

Active Ingredients

Drugs in Phase 3 Trials (4)

amlodipine (norvasc) (1 trial)

indapamide (lozol) (1 trial)

paclitaxel (taxol) (5 trials)

valsartan (diovan) (1 trial)

Drugs in Phase 2 Trials (2)

dhp1401 (1 trial)

donepezil (aricept) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Breast Neoplasms (Phase 3)

Stomach Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 6